• Articles

    Recent FDA Approvals Continue to Focus on Targeted and Immunotherapy
  • Articles

    FDA Approves Betrixaban for Extended Duration Prophylaxis of Venous Thromboembolism
  • Articles

    Critical Care for Patients With Cancer
  • Articles

    How Can Oncology and ICU Nurses Work Together to Treat Critically Ill Patients With Cancer?
  • Articles

    Data Aggregate System Seeks Oncology Nurse Ambassadors
  • Articles

    Oncology Treatments and Trends Continue to Change Rapidly
  • Articles

    FDA Approves L-Glutamine Powder for the Treatment of Sickle Cell Disease
  • Articles

    Up-Front Palliative Care Consultation Associated With Better Outcomes in Advanced Cancer
  • Articles

    FDA Grants Regular Approval to Blinatumomab and Expands Indication to Include Philadelphia Chromosome-Positive B Cell ALL
  • Articles

    ONS Answers Your Top Questions About Cancer Immunotherapy